SMITH STAN purchased 0.2% of their position (2.70K shares) of MAIA BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $10.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/12/2026ACC: 0001878313-26-000021
+22.70K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
22.70K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+2.70K
Price / share
$3.69
Trade value
$9.96K
% of position
0.2%
9/19/2022
1.42M→1.42M
Common Stock
Indirect
Shares
+20K
Price / share
—
Trade value
—
% of position
1.4%
5/1/2024
1.42M→1.44M
Total
Net shares
+22.70K
Net value
$9.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/19/2022 | P · Purchase | +2.70K | $3.69 | $9.96K | 0.2% | 1.42M | 1.42M |
| Common Stock Indirect | 5/1/2024 | G · Gift | +20K | — | — | 1.4% | 1.42M | 1.44M |
| Total | +22.70K | $9.96K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned4.58K
Common Stock
IndirectShares owned4.58K
Common Stock
IndirectShares owned4.58K
Total
13.74K indirect13.74K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.58K | Indirect |
| Common Stock | 4.58K | Indirect |
| Common Stock | 4.58K | Indirect |
| Total | 13.74K | 13.74K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported